Alpha DNA Investment Management’s MACOM Technology Solutions MTSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,253
Closed -$423K 112
2024
Q4
$423K Buy
+3,253
New +$409K 0.16% 160
2021
Q2
Sell
-8,477
Closed -$491K 435
2021
Q1
$491K Buy
8,477
+8,408
+12,186% +$521K 0.56% 93
2020
Q4
$3K Buy
+69
New +$2.94K ﹤0.01% 420

Other funds holding MTSI

Alpha DNA Investment Management's MTSI Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of MACOM Technology Solutions (MTSI) in Q1 2025, closing a stake of 3,253 shares — an estimated $423K sold.

Alpha DNA Investment Management first reported a position in MTSI in Q4 2020 and held it in 3 quarters. The position peaked at $491K in Q1 2021. 385 funds tracked by Wall St. Rank hold MTSI as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining MACOM Technology Solutions position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,253 MACOM Technology Solutions shares in Q1 2025, an estimated $423K.
  • Alpha DNA Investment Management first reported a position in MACOM Technology Solutions in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's MACOM Technology Solutions position peaked at $491K in Q1 2021.
  • 385 funds tracked by Wall St. Rank held MACOM Technology Solutions as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.